Congenital adrenal hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{21-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==[[ | ==[[21-hydroxylase deficiency overview|Overview]]== | ||
==[[ | ==[[21-hydroxylase deficiency historical perspective|Historical Perspective]]== | ||
==[[ | ==[[21-hydroxylase deficiency classification|Classification]]== | ||
==[[ | ==[[21-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[21-hydroxylase deficiency causes|Causes]]== | ||
==[[ | ==[[21-hydroxylase deficiency differential diagnosis|Differentiating Congenital Adrenal Hyperplasia from other Diseases]]== | ||
==[[ | ==[[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[21-hydroxylase deficiency risk factors|Risk Factors]]== | ||
==[[ | ==[[21-hydroxylase deficiency screening|Screening]]== | ||
==[[ | ==[[21-hydroxylase deficiency natural history|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== |
Revision as of 13:19, 12 July 2017
21-hydroxylase deficiency Microchapters |
Differentiating 21-Hydroxylase Deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Congenital adrenal hyperplasia On the Web |
American Roentgen Ray Society Images of Congenital adrenal hyperplasia |
Risk calculators and risk factors for Congenital adrenal hyperplasia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Congenital Adrenal Hyperplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies